Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The market trends of musculoskeletal system disorders reflect a growing concern, with an increasing prevalence and incidence globally. As the aging population rises and lifestyle factors contribute to the development of these disorders, there is a noticeable uptick in the number of individuals affected.
The market is starkly dominated by dominance of orthopedic devices. As the number of joint replacements, spinal implants, and trauma fixation devices increases rapidly these manufacturers in this sector are having accelerated growth. The other development in the market which is also affecting it tremendously are technological innovations, such as minimally invasive procedures.
The sports medicine segment is registering massive growth on the back of increased injuries among more. The various groups of people requiring orthopedic treatment with increasing intensity would be athletes and fitness enthusiasts who seek innovative approaches in the form or advanced rehabilitation techniques for quick recovery, as well products developed specifically to address their sport related needs.
Significantly, regenerative medicine is increasingly being used. Stem cell treatments, tissue engineering and growth factor applications are increasingly being adopted as an option for patients seeking to avoid the traditional surgical interventions. This move towards regenerative approaches is reshaping the treatment terrain.
There is a growing role of advances in diagnostic technologies like imaging modalities and diagnostics biomarkers, early detection of disease and intervention. The incorporation of artificial intelligence in diagnostics simplifies the identification and categorization process by recognizing multiple musculoskeletal conditions, providing more robust it personalized treatment solutions.
Biologics administration in the field of orthopedic medicine is becoming increasingly popular, giving towards tissue healing and repair. Also, biologic therapies such as platelet-rich plasma (PRP) and growth factor injections increasingly attract the attention of athletes because they are believed to help speed recovery time with minimized need for conventional surgeries.
The pattern of MSK market is to move patient-orientate from the care. Surgeons and medical equipment manufacturers are more interested in improving clinical results, quality of care for the patient’s populations treated by them as well as postoperative outcomes. This tendency encourages patient-specific treatment plans and rehabilitation strategies.
Apart from healthcare policies and reimbursement mechanisms, the market trends are also dictated by these. The reforms on the compensation system and policies ply a key role in content of accessibility of musculoskeletal treatments which forces healthcare suppliers or manufacturers to alter their strategies consequently adapting with new regulatory settings.
Collaborations and partnerships between pharmaceutical companies, medical device manufacturers, and research institutions are fostering innovation in musculoskeletal disorder treatments. These strategic alliances aim to combine expertise, resources, and research efforts to address the multifaceted challenges associated with these disorders.
The COVID-19 pandemic has accelerated the adoption of telemedicine and remote monitoring in musculoskeletal care. Virtual consultations, remote rehabilitation programs, and digital health platforms are becoming integral components of musculoskeletal healthcare delivery, providing patients with convenient access to specialized care.
Musculoskeletal System Disorders Market Highlights:
Global Musculoskeletal System Disorders Market Overview
The musculoskeletal system disorders market is expected to reach USD 6.07 Billion by 2032 at 6.8% CAGR during the forecast period 2024-2032.
The number of musculoskeletal system disorder cases is increasing globally, fueling musculoskeletal system disorder market growth. Musculoskeletal system disorders are the second-highest contributor to global disability and an estimated 20%–33% of people across the globe live with a painful musculoskeletal condition.
Musculoskeletal disorders are most common in low- and middle-income countries and these disorders require lifelong care to manage.
Musculoskeletal System Disorders Market Influencer
Rising prevalence of musculoskeletal disorders and increasing reimbursement offered to patients by health insurance providers.
Musculoskeletal System Disorders Market Drivers
- Growing global geriatric population.
- Change in lifestyle habits leading to bad posture, which is increasing the prevalence of musculoskeletal system disorders.
- Increasing research and development of new drugs to treat musculoskeletal disorders. For instance, in 2017–2018, the National Institute of Health Research (NIHR) spent approximately USD 13.46 million (GBP 11.1 million) on research on musculoskeletal disorders.
- Rising prevalence of work-related musculoskeletal disorders. For example, the prevalence in the fiscal year 2017–2018 was about 469,000 in the UK.
- Rising awareness of advanced treatment for musculoskeletal disorders.
- Launch of new medication to manage the symptoms of chronic musculoskeletal system disorders.
Musculoskeletal System Disorders Market Restraints
- High treatment costs.
- Availability of alternative therapies such as traditional medicine and physiotherapy
- Need for specialized equipment to diagnose and treat musculoskeletal system disorders.
Musculoskeletal System Disorders Market Segment Insights
Musculoskeletal System Disorders Type Insights
- Rheumatoid Arthritis: The largest segment of the musculoskeletal system disorder market, rheumatoid arthritis afflicts almost 1% of the entire global population and is three times as likely to afflict women than men.
- Osteoarthritis: This disorder generally afflicts elderly people. As of 2018, about 9.6% of men and 18% of women over 60 had symptomatic osteoarthritis worldwide and over a quarter of those afflicted could not perform daily activities.
- Osteoporosis: The fastest-growing segment, over 75 million people suffer from osteoporosis in Europe, the US, and Japan. This number is growing in developing countries and the disorder is responsible for millions of fractures worldwide. By 2050, osteoporosis is expected to be responsible for a 310% increase in hip fractures for men and a 240% increase for women, as compared to rates in 1990.
- Psoriatic Arthritis: This autoimmune disorder afflicts roughly 3 out of every 10 individuals who have psoriasis. With over 100 million people afflicted globally with psoriasis, psoriatic arthritis afflicts almost 30 million individuals.
- Ankylosing Spondylitis: The tendency to develop this condition is genetic, with males twice to three times more likely to be afflicted than women.
- Fibromyalgia: A very common ailment, about 80%–90% of sufferers of fibromyalgia are women.
- Others: This segment covers musculoskeletal disorders such as tendinitis and carpal tunnel syndrome.
Musculoskeletal System Disorders Treatment Insights
- Biologics: The fastest-growing segment, biologics find increasing application in the treatment of rheumatoid arthritis. A rise in the number of FDA approvals for biologics to treat musculoskeletal system disorders is a key factor for the growth of the segment.
- Corticosteroids: The largest segment, corticosteroids are the preferred treatment for many musculoskeletal system disorders as they reduce inflammation and suppress immune system activity.
- Physical Therapy: Used to manage almost all chronic musculoskeletal system disorders, physical therapy is prescribed in conjunction with medication.
- Extracorporeal Shock Wave Therapy: Used to manage pain, this therapy excels in providing fast-acting relief without the use of painkillers. Used extensively in managing musculoskeletal system disorders.
- Protein Therapy: A novel method used to combat several musculoskeletal system disorders; it involves the ingestion of protein via changes in diet and artificially produced proteins.
- Synthetic Bone Graft: An expensive and complex treatment option, synthetic bone grafts have been used to replace bones made too brittle by osteoporosis and other musculoskeletal system disorders.
- Composite Grafts: Used for several bone replacement and repair procedures.
- Demineralized Bone Matrix: The treatment method is used in bone transplants where the biological activity of the graft is more important than its mechanical properties.
- Others: This segment covers alternative treatment methods such as gene therapy and chiropractic care.
Musculoskeletal System Disorders End User Insights
- Hospitals and Clinics: The largest segment, hospitals and clinics are usually the primary points for diagnosis, treatment, and rehabilitation of individuals afflicted with musculoskeletal system disorders. Growing awareness and increasing efficiency of musculoskeletal system disorder treatment are projected to drive the growth of this segment during the forecast period.
- Ambulatory Surgical Centers: A small segment, these centers provide immediate pain relief and rudimentary surgical care.
- Others: This segment includes home care and senior citizen centers.
Musculoskeletal System Disorders Regional Insights
- Americas: The largest regional market, the prevalence of musculoskeletal system disorders is high in the Americas; the region also has a well-established healthcare industry.
- Europe: An increasing geriatric population is leading to a rise in the number of musculoskeletal system disorder cases.
- Asia-Pacific: The fastest-growing regional market, Asia-Pacific is seeing a surge in the number of people afflicted with musculoskeletal system disorders due to bad posture brought on by lifestyle changes, aging, and genetic predisposition.
- Middle East & Africa: The smallest market due to limited healthcare infrastructure and a very young population.
Musculoskeletal System Disorders Market Top Key Players
- AB Science (France)
- AbGenomics International, Inc. (US)
- Alder BioPharmaceuticals,Inc. (US)
- Amgen Inc. (US)
- Lexicon Pharmaceuticals, Inc. (US)
- LG Chem (South Korea)
- OrthoTrophix, Inc. (US)
- Tarsa Therapeutics, Inc. (US)
- PhytoHealth Corporation (Taiwan)
- Eisai Co., Ltd (Japan)
- Astellas Pharma Inc. (Japan)
- AstraZeneca (UK)
- Baxter (US)
- GlaxoSmithKline PLC (UK)
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
